| abstract |
The present invention relates to a method of treating SLE in a subject comprising administering to the subject an amount of an HIV protease inhibitor effective to treat systemic lupus erythematosus (SLE). The present invention also relates to a pharmaceutical product comprising an HIV protease inhibitor formulated in a pharmaceutically acceptable carrier and a package insert indicating instructions for administration of the HIV protease inhibitor for the treatment of SLE. . Furthermore, the invention relates to the use of an HIV protease inhibitor for the preparation of a medicament for the treatment of SLE. |